Metabolomic insights and bioactive efficacies of Tragopogon dubius root fractions: Antioxidant and antiproliferative assessments

• Published in: Heliyon Vol. 10; no. 16; p. e34746
• Main Authors: Ahmad, Sheikh Showkat, Garg, Chandni, Kour, Rasdeep, Bhat, Aashaq Hussain, Raja, Vaseem, Gandhi, Sumit G., Ataya, Farid S., Fouad, Dalia, Radhakrishnan, Arunkumar, Kaur, Satwinderjeet
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 30.08.2024; Elsevier
• Subjects: Anticancer activity; Antioxidant activity; Apoptosis; GC-MS; Phytochemicals; Thin layer chromatography; Tragopogon dubius; GC-MS; Thin layer chromatography; Phytochemicals; Antioxidant activity; Anticancer activity; Tragopogon dubius; Apoptosis
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e34746

Tragopogon dubius is commonly consumed as a vegetable and used in traditional medicine for treating inflammatory skin conditions and cutaneous swelling. Despite known pharmacological properties of its leaves and roots, many of its biological characteristics and active phytochemicals remain unexplored. The present study investigates the phytochemical composition, antioxidant, and anticancer properties of methanolic root extracts and isolated fractions (TdRM-1 and TdRM-2) of T. dubius. Utilizing preparative thin-layer chromatography, the crude extract was successfully separated into TdRM-1 and TdRM-2, characterized by GC-MS and FTIR analysis, revealing a diverse range of bioactive compounds including terpenes, flavonoids, and phenolic acids. Qualitative phytochemical screening indicated the presence of carbohydrates, tannins, alkaloids, and other phytoconstituents. Advanced UPLC-ESI-QTOF-MS analysis identified 54 metabolites, significantly contributing to the chemical profiling of the extract. The antioxidant activities of the fractions were quantitatively assessed using ABTS, DPPH, and superoxide radical scavenging assays, where TdRM-2 exhibited superior activity with IC50 values ranging from 51.29 to 60.03 μg/mL. Anticancer potential was evaluated against A549, LN-18, and MCF-7 cancer cell lines, demonstrating that TdRM-2 significantly inhibited cell proliferation with GI50 values as low as 31.62 μg/mL for A549 cells. Additionally, fluorescence microscopy revealed that TdRM-2 induces apoptosis, indicated by changes in nuclear morphology and loss of mitochondrial membrane potential. Annexin V-FITC/PI double staining indicate that the TdRM-2 fractions from T. dubius can significantly inhibit the growth of A-549, LN-18, and MCF-7 cancer cell lines by inducing apoptosis These findings suggest that T. dubius root extracts, particularly the TdRM-2 fraction, hold promising therapeutic potential due to their significant antioxidant and anticancer activities, underpinned by their rich phytochemical composition. This study underscores the importance of T. dubius as a source of natural bioactive compounds with potential health benefits.